Phreesia, Inc. (NYSE:PHR) Short Interest Update

Phreesia, Inc. (NYSE:PHR) was the recipient of a large decline in short interest in the month of December. As of December 15th, there was short interest totaling 2,427,866 shares, a decline of 30.2% from the November 30th total of 3,479,944 shares. Currently, 4.3% of the shares of the company are short sold. Based on an average daily volume of 2,620,410 shares, the short-interest ratio is presently 0.9 days. Based on an average daily volume of 2,620,410 shares, the short-interest ratio is presently 0.9 days. Currently, 4.3% of the shares of the company are short sold.

Analyst Ratings Changes

Several equities analysts have weighed in on PHR shares. JMP Securities lifted their price objective on Phreesia from $30.00 to $34.00 and gave the company a “market outperform” rating in a report on Monday, September 8th. Canaccord Genuity Group decreased their price target on Phreesia from $38.00 to $33.00 and set a “buy” rating on the stock in a research report on Tuesday, December 9th. Stephens reaffirmed an “overweight” rating and issued a $32.00 price target on shares of Phreesia in a research note on Wednesday, September 3rd. KeyCorp cut their price objective on shares of Phreesia from $35.00 to $32.00 and set an “overweight” rating for the company in a research report on Wednesday, October 8th. Finally, Truist Financial set a $29.00 target price on shares of Phreesia in a report on Wednesday, December 10th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $31.00.

Phreesia Price Performance

Shares of PHR stock traded up $0.02 on Tuesday, reaching $17.02. The company had a trading volume of 970,490 shares, compared to its average volume of 1,875,143. The business’s 50-day moving average is $19.95 and its 200 day moving average is $24.22. Phreesia has a one year low of $15.41 and a one year high of $32.76. The company has a quick ratio of 2.44, a current ratio of 2.44 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $1.03 billion, a PE ratio of -170.13 and a beta of 0.64.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Monday, December 8th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.11. The company had revenue of $120.33 million for the quarter, compared to analyst estimates of $119.98 million. Phreesia had a negative net margin of 1.16% and a negative return on equity of 1.31%. The firm’s revenue was up 12.7% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.25) EPS. Equities research analysts forecast that Phreesia will post -1.1 EPS for the current fiscal year.

Insider Buying and Selling at Phreesia

In other Phreesia news, insider David Linetsky sold 2,059 shares of the stock in a transaction that occurred on Friday, October 17th. The shares were sold at an average price of $22.36, for a total transaction of $46,039.24. Following the transaction, the insider owned 171,829 shares in the company, valued at $3,842,096.44. This represents a 1.18% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Evan Roberts sold 1,888 shares of the firm’s stock in a transaction that occurred on Friday, October 17th. The stock was sold at an average price of $22.36, for a total transaction of $42,215.68. Following the transaction, the insider directly owned 724,949 shares in the company, valued at $16,209,859.64. This represents a 0.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 7,534 shares of company stock valued at $165,514 in the last quarter. Company insiders own 5.50% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of PHR. Federated Hermes Inc. acquired a new stake in shares of Phreesia during the 3rd quarter valued at $32,000. Asset Management One Co. Ltd. bought a new position in Phreesia in the third quarter valued at about $45,000. State of Alaska Department of Revenue acquired a new stake in shares of Phreesia during the third quarter valued at about $83,000. Farther Finance Advisors LLC boosted its stake in shares of Phreesia by 9,375.0% during the second quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock valued at $86,000 after purchasing an additional 3,000 shares in the last quarter. Finally, Anchor Investment Management LLC bought a new stake in shares of Phreesia during the third quarter worth about $118,000. 92.10% of the stock is currently owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.